Optimax
A UK laser eye and lens surgery provider operating clinics across the country.
Last updated August 22, 2026
AI crawler reads
4requests
1companies- Anthropic4
- Profile
- 2
- Controversies
- 2
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Optimax is a British specialist provider of elective ophthalmic procedures, principally laser vision correction and lens-based eye surgery. The company was established in 1991 and is based in Birmingham, England. Its services are delivered through a network of clinics across the United Kingdom, supported by ophthalmic surgeons, optometrists and other clinical staff. The brand operates in the private healthcare market, where patients typically pay directly for refractive procedures intended to reduce or eliminate dependence on spectacles or contact lenses. Its principal treatment categories include laser procedures such as LASIK and LASEK, as well as other forms of laser vision correction and lens surgery. Optimax has promoted its use of technologies including femtosecond lasers, IntraLASIK and Schwind laser systems. The business reached a reported milestone in 2002 when it performed its 100,000th laser eye surgery procedure. During the 2000s and 2010s, Optimax was identified as one of the three principal companies in the UK laser eye surgery market, alongside Optical Express and Ultralase. The three groups were reported together as accounting for approximately 56% of UK clinics, although the cited figure is historical and does not describe the current market. Ownership and corporate relationships have been closely associated with Russell Keith Ambrose. In December 2012, Ambrose acquired Ultralase Ltd, creating a relationship between the two businesses. Ultralase Eye Clinics Limited and Optimax have subsequently been described as sister companies within the Eye Hospitals Group structure, sharing certain clinics, surgeons and optometrists and operating as related businesses. Optimax has also faced public scrutiny connected with patient advocacy and disputes involving competitors. In 2014, Nominet dismissed a complaint brought by Optical Express concerning an allegedly critical website and its alleged funding. The dispute involved campaigner Sasha Rodoy, who had undergone LASEK surgery at Optimax in 2011 and said that the procedure had caused permanent eye damage. The episode is documented as a dispute and allegation rather than a finding that Optimax committed wrongdoing. In November 2020, Optimax Clinics Ltd entered a four-year Company Voluntary Arrangement after stating that it was insolvent. A CVA is a formal arrangement with creditors and does not necessarily mean that a trading business has ceased operations. The available reference material does not provide sufficient detail to assess the arrangement's final outcome or its effect on the broader Optimax brand. Optimax remains presented as an operating UK provider of laser and lens eye surgery, but detailed current financial, ownership and clinic-network information is not established by the supplied sources.
History
Optimax was established in the United Kingdom in 1991 as a provider of elective laser eye treatment. Its business developed during the expansion of private refractive surgery, when advances in laser technology enabled clinics to market procedures that could reduce patients' reliance on glasses and contact lenses. The company reached an early scale milestone in 2002, when it performed its 100,000th laser eye surgery procedure. Optimax subsequently operated clinics throughout the UK and broadened its offering beyond a single laser procedure to include multiple forms of laser vision correction and lens eye surgery. The brand has highlighted the introduction or use of femtosecond laser technology, IntraLASIK and Schwind lasers as part of its technology proposition. Historically, Optimax was described as one of the three leading companies in the UK laser eye surgery market, together with Optical Express and Ultralase. Those companies were reported collectively to account for approximately 56% of UK clinics. This description relates to the market at the time of the cited source and should not be treated as a current market-share estimate. Russell Keith Ambrose has been identified as the owner of Optimax. In December 2012, he acquired Ultralase Ltd. The two businesses later operated as related companies: Ultralase Eye Clinics Limited and Optimax were described as sister companies under Eye Hospitals Group Limited, with shared clinics, surgeons and optometrists. The relationship allowed the businesses to function as part of a common operating family while retaining their respective brand identities. The company became involved in public controversy in connection with patient advocacy and online criticism of a competing provider. In April 2014, Nominet dismissed a complaint from Optical Express alleging that Ambrose had funded a website critical of Optical Express. The website's author, Sasha Rodoy, was associated with the My Beautiful Eyes Foundation and described herself as a patient advocate. Rodoy had undergone LASEK treatment at Optimax in 2011 and said that the surgery had irreparably damaged her eyes. The available account records the complaint and the allegation but does not establish an independent clinical or legal finding against Optimax. A further corporate turning point occurred in 2020. On 27 November, Optimax Clinics Ltd entered a four-year Company Voluntary Arrangement after claiming insolvency. The arrangement was a formal creditor process, but the supplied material does not state the amount of debt, creditor recovery terms, or final result. Nor does it establish whether the CVA applied to every entity using the Optimax brand. Optimax continues to be described as a UK provider of laser and lens eye surgery. Its historical identity combines an established national clinic presence, a technology-led refractive-surgery proposition and corporate links to Ultralase. Current clinic numbers, leadership beyond the identified owner, financial performance and the post-CVA corporate structure require verification from up-to-date company and regulatory records.
- 2020
Company Voluntary Arrangement
[1]Optimax Clinics Ltd enters a four-year CVA after stating that it was insolvent.
- 2014
Nominet dismisses Optical Express complaint
[1]Nominet dismisses a complaint concerning an allegedly competitor-critical website and its alleged funding.
- 2012
Ultralase acquisition
[1]Russell Keith Ambrose acquires Ultralase Ltd, establishing a close corporate relationship with Optimax.
- 2002
100,000th laser eye surgery procedure
[1]The company reports completing its 100,000th laser eye surgery procedure.
- 1991
Optimax is established
[1]Optimax is founded as a UK provider of laser eye treatment.
Products and positioning
An established, high-volume UK private provider of laser vision correction and related ophthalmic procedures.
Laser vision correction
LASIK
LASIK is a refractive eye procedure in which a corneal flap is created and laser treatment reshapes the underlying corneal tissue. Optimax lists LASIK among its principal vision-correction services. Suitability, risks and expected outcomes depend on individual clinical assessment.
Laser vision correction
LASEK
LASEK is a surface-based laser refractive procedure that treats the cornea without creating the same type of stromal flap used in LASIK. It is one of the procedures associated with Optimax's treatment portfolio and has also featured in public discussion involving a former patient.
Laser vision correction technology
IntraLASIK
IntraLASIK is a technology-associated form of LASIK in which a femtosecond laser is used in the flap-creation stage. Optimax has advertised itself as an early UK introducer of femtosecond laser and IntraLASIK technology.
Lens-based ophthalmic surgery
Lens eye surgery
In addition to corneal laser procedures, Optimax provides lens-based eye surgery. The supplied sources do not identify the complete product range, named procedures or current eligibility criteria within this category.
Controversies
2014
Optical Express complaint and patient-damage allegations
Nominet dismissed an Optical Express complaint concerning a website critical of Optical Express and alleged funding by Russell Keith Ambrose. The matter also drew attention to Sasha Rodoy's allegation that LASEK surgery performed at Optimax in 2011 had caused irreparable eye damage. The supplied reference does not establish a legal or regulatory finding that Optimax caused the alleged harm.
Brand decisions
2020
Entry into a Company Voluntary ArrangementOtherBackground
Optimax Clinics Ltd stated that it was insolvent.
Action taken
On 27 November 2020, the company entered a four-year Company Voluntary Arrangement with creditors.
Aftermath
The supplied sources do not provide the arrangement's financial terms, completion status or full effect on the wider Optimax group.
2012
Acquisition of UltralaseM&ABackground
The UK laser eye surgery market included Optimax, Ultralase and Optical Express as prominent operators.
Action taken
Russell Keith Ambrose acquired Ultralase Ltd.
Aftermath
Ultralase Eye Clinics Limited and Optimax were subsequently described as sister companies within Eye Hospitals Group Limited, sharing selected operational resources.
Recent events
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/optimax · Editorial policy · How profiles are compiled